Archived Newsletters

31. 10.02.25 -- Why Process Safety Matters — And What's Next For Pharma Manufacturing 10/2/2025

    10/02/25 Outsourced Pharma Newsletter

32. 10.02.25 -- Execute Or Decay: Radiopharma's Outsourcing Reality 10/2/2025
    10/02/25 Outsourced Pharma Newsletter
33. 10.01.25 -- Gain Access To Tailored Bioanalytic Services. 10/1/2025
    10/01/25
34. 10.01.25 -- How Can Nanotechnology Transform Drug Delivery? 10/1/2025

    10/01/25 Outsourced Pharma Newsletter

35. 10.01.25 -- You're In Charge Of Strategic Sourcing? What's That Actually Mean? 10/1/2025
    10/01/25 Outsourced Pharma Newsletter
36. 09.30.25 -- From Single-Use To Continuous Manufacturing: Strategies Shaping Biopharma 9/30/2025

    09/30/25 Outsourced Pharma Newsletter

37. 09.30.25 -- Lilly's Kinsale Facility Provides A Benchmark For Your CDMO Selection 9/30/2025
    09/30/25 Outsourced Pharma Newsletter
38. 09.29.25 -- Application Of Process Analytical Technology In ADC Bioconjugation Processes 9/29/2025

    09/29/25 Outsourced Pharma Newsletter

39. 09.29.25 -- STREAM Edition: Dye Drug Conjugates For Cancer With Lahjavida's Lyle Small 9/29/2025

    09/29/25 Outsourced Pharma Newsletter

40. 09.29.25 -- Buckle Up. It's A Strategic Drive To Successful Sourcing 9/29/2025
    09/29/25 Outsourced Pharma Newsletter